Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cellebrite DI Ltd. - Ordinary Shares (NQ:CLBT)

11.12 +0.12 (+1.05%)
Streaming Delayed Price Updated: 3:02 PM EDT, Aug 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cellebrite DI Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >
News headline image
Stock Market Today, Aug. 13: Cellebrite Shares Plummet 29% After Missing Earnings, Cutting 2026 Revenue Guidance ↗
On Aug. 13, 2026, the digital forensics firm reported delays in large transactions and heightened demand for cloud and AI procurement, prompting a leadership change. 
Via The Motley Fool
Topics Artificial Intelligence Earnings Initial Public Offering
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Cellebrite DI Ltd (NASDAQ:CLBT) Q1 Results Miss Revenue Target but Beat EPS ↗
Via Chartmill
Cellebrite DI Ltd (NASDAQ:CLBT) Reports Record Q4 2025 Results Amid Mixed Market Reaction ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Cellebrite DI Q2 Earnings Call Highlights ↗
Cellebrite DI (NASDAQ:CLBT) reported second-quarter results that fell short of its expectations for annual recurring revenue, citing delayed large transactions, slower-than-anticipated pricing and... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Full Transcript: Cellebrite DI Q2 2026 Earnings Call ↗
Cellebrite DI (NASDAQ:CLBT) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to... 
Via Benzinga
Topics Earnings
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Cellebrite CEO Thomas Hogan Sells 103,000 Shares for $1.6 Million: Is This a Concern for Investors? ↗
Hogan's non-discretionary sale satisfied tax withholding obligations from vesting RSUs. He retains 590,777 shares worth $9.25 million. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market ↗
Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Stride Stock Is Down 40% This Past Year. Here's Why One Investor Added $58 Million ↗
Stride, Inc. delivers technology-driven education solutions for K-12 students and adult learners through proprietary online platforms. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Choice Hotels Stock Is Down 15%, but One Investor Bought $101 Million Last Quarter ↗
This global franchisor operates well-known hotel brands and provides technology solutions to owners across dozens of countries. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows ↗
Cellebrite DI (NASDAQ:CLBT) executives said the company is seeing broader customer adoption of its digital investigations platform, with artificial intelligence, cloud migration and U.S. federal... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
What to Know About This Fund's $59 Million Astronics Bet Amid a 170% One-Year Stock Surge ↗
Astronics Corporation delivers advanced electronic systems and test solutions to aerospace and defense clients worldwide. 
Via The Motley Fool
Topics Energy Regulatory Compliance Supply Chain
News headline image
This Chip Stock Soared 325%. Why One Investor Still Sold $89 Million Worth ↗
Silicon Motion Technology designs NAND flash controllers and storage solutions for global OEMs, hyperscalers, and electronics distributors. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth ↗
Cellebrite DI (NASDAQ:CLBT) executives said the digital investigations company is seeing renewed momentum in government demand, international markets and new product categories, including artificial... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Cellebrite (CLBT) Q1 2026 Earnings Transcript ↗
Cellebrite (CLBT) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cellebrite DI Q1 Earnings Call Highlights ↗
Cellebrite DI (NASDAQ:CLBT) reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Cellebrite: Is This Stock Worth the Investment? ↗
Is Cellebrite a hidden gem in the tech industry or just another overhyped stock? Join us as we break down its strengths and weaknesses in this insightful analysis. 
Via The Motley Fool
News headline image
IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter ↗
This medical device firm supplies MRI-compatible equipment to healthcare providers through direct sales and a specialized network. 
Via The Motley Fool
News headline image
Resolute Holdings Stock Soars 400% as Nine Ten Trims $5 Million From Stake ↗
This New York alternative asset manager delivers tailored investment solutions and reported notable profitability in its latest filing. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cellebrite (CLBT) Q4 2025 Earnings Call Transcript ↗
Cellebrite (CLBT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Norwood Investment Partners Opens New $4.3 Million Cellebrite Position ↗
Norwood Investment Partners initiated a new position in Cellebrite, despite the stock having already risen over 30% from its 52-week low. 
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
10 AI Stocks Worth Buying Right Now ↗
Building an artificial intelligence (AI) portfolio means looking beyond the obvious megacap names. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Should Investors Buy Shares of Cellebrite Alongside Portolan Capital as They Double Down on the Stock? ↗
Portolan opened a position in Cellebrite early in 2024 and doubled down on the stock in the third quarter, making the company its tenth-largest holding. 
Via The Motley Fool
News headline image
These Fast-Rising Tech Stocks Are Surging in Growth Scores This Week ↗
 
Via Benzinga
News headline image
This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know ↗
A high-conviction fund just trimmed one of its biggest winners—here’s what long-term investors should make of the move. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Small-Cap Fund Bought $11 Million in Cellebrite Stock Last Quarter ↗
A specialist small-cap fund just doubled down on a digital-intelligence company that's underperforming the broader market. 
Via The Motley Fool
News headline image
This Fund Cut $7.3 Million of Atlas Energy Stock as the Company Suspends Its Dividend to Help Fuel Growth ↗
One fund just took a step back from a struggling energy name—right as the company suspended its dividend to fund future growth. 
Via The Motley Fool
Topics Economy Regulatory Compliance
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.